Sökning: "Per-Ola Carlsson"
Visar resultat 6 - 10 av 19 avhandlingar innehållade orden Per-Ola Carlsson.
6. Auxiliary Cells for the Vascularization and Function of Endogenous and Transplanted Islets of Langerhans
Sammanfattning : Type 1 diabetes develops through the progressive destruction of the insulin-producing beta-cells. Regeneration or replacement of beta-cells is therefore needed to restore normal glucose homeostasis. Presently, normoglycemia can be achieved by the transplantation of whole pancreas or isolated islets of Langerhans. LÄS MER
7. Predictors of long-term glycemic control, pancreatic function and BMI trajectory in children with type 1 diabetes
Sammanfattning : Background: The maintenance of normal metabolic control underpins all management of insulin dependent diabetes whether in terms of preserved beta-cell function, body composition, or family support. The hypothesis of this work was that preserved C-peptide predicts better glycemic control and lowers risk of severe hypoglycemia. LÄS MER
8. Role of Islet Endothelial Cells in β-cell Function and Growth
Sammanfattning : The pancreatic islets are collections of endocrine cells, dispersed throughout the pancreas. In adult islets, endocrine cells are closely associated with capillary endothelial cells and receive a high blood perfusion. Transplanted pancreatic islets, on the other hand, have a vascular disturbance, manifested as decreased blood vessel density. LÄS MER
9. Properties of Endothelium and its Importance in Endogenous and Transplanted Islets of Langerhans
Sammanfattning : Transplantation of insulin producing cells is currently the only cure for type 1 diabetes. However, even though the Edmonton protocol markedly increased the success rate of pancreatic islet transplantation, the long term insulin independence is still very poor. An adequate engraftment is critical for islet graft survival and function. LÄS MER
10. Bariatric surgery as treatment of type 2 diabetes – clinical and mechanistic aspects
Sammanfattning : Bariatric surgery can rapidly improve glycemic control and cardiovascular risk factors in patients with T2D and obesity. These improvements appear to be partly independent of weight loss, however, the underlying mechanisms remain incompletely understood. LÄS MER